Pioneering innovative therapies to improve the lives of those with genetic intellectual disabilities
On March 10th, the Jerome Lejeune Foundation in Paris organized a major event at the European Parliament in Strasbourg, France to highlight progress being made in Down syndrome research.
U.S. Foundation president, Mark Bradford, was asked to attend the event in order to share with members of the European Parliament what the U.S. government is doing to support those living with Down syndrome.
The NIH is often criticized for the disproportionately low level of funding it provides to researchers working in Down syndrome. Funding for Down syndrome research has ranged between $18 and $20 million for the last several years, and at present averages only about $72 per person. However, in spite of poor funding, there is a strong commitment by the staff at the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) to those living with Down syndrome.
The following are some of the NIH programs Mr. Bradford shared with the European Parliament that support the Down syndrome community in the U.S.:
Advocates must continue to lobby for increased funding for research in Down syndrome, but it is important to acknowledge and to thank the committed group of administrators at the NIH who are working as effectively and as strategically as they can with the limited resources allocated to them.
The Jerome Lejeune Foundation (France and the U.S.) was founded in 1996 to carry on the work of the legendary geneticist, Jerome Lejeune. Through its mission of research, care, and advocacy, the Jerome Lejeune Foundation serves those with Down syndrome and other genetic intellectual disabilities in a spirit of profound respect for their inherent human dignity, and that of all human persons.